4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001688199-26-000004
Director sold 2,777 shares at an average $109.55 ($304,232)
- Director acquired 2,777 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Read Simon Director | 2026-08-10 | Option exercise 10b5-1 | +2,777 | $18.36 | $50,986 | 2,777 | D |
| Read Simon Director | 2026-08-10 | Sale 10b5-1 | −70 | $107.11 | $7,498 | 2,707 | D |
| Read Simon Director | 2026-08-10 | Sale 10b5-1 | −737 | $108.17 | $79,721 | 1,970 | D |
| Read Simon Director | 2026-08-10 | Sale 10b5-1 | −831 | $108.95 | $90,537 | 1,139 | D |
| Read Simon Director | 2026-08-10 | Sale 10b5-1 | −272 | $109.96 | $29,909 | 867 | D |
| Read Simon Director | 2026-08-10 | Sale 10b5-1 | −470 | $111.05 | $52,194 | 397 | D |
| Read Simon Director | 2026-08-10 | Sale 10b5-1 | −397 | $111.77 | $44,373 | 0 | D |
| Derivatives | |||||||
| Read Simon Director | 2026-08-10 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,777 | 22,223 | D | ||
| Open-market sales · 2,777 sh · avg $109.55 · $304,232 | |||||||
Loading xslF345X06/ownership.xml…